Chemotherapeutic agents doses epirubicin. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy6

Cell Line, Tumor Tumor Cells, Cultured Cell Line HCT116 Cells MCF-7 Cells Neoplastic Stem Cells

Organisms3

Mice, Nude Mice, Inbred BALB C Mice, SCID

Diseases35

Breast Neoplasms Neoplasms Lung Neoplasms Adenocarcinoma Neoplasm Metastasis Ovarian Neoplasms Neutropenia Colonic Neoplasms Stomach Neoplasms Liver Neoplasms Vomiting Alopecia Neoplasms, Experimental Nausea Pancreatic Neoplasms Bone Neoplasms Leukopenia Brain Neoplasms Hematologic Diseases Carcinoma, Hepatocellular Carcinoma Prostatic Neoplasms Carcinoma, Small Cell Neoplasm Recurrence, Local Melanoma Heart Diseases Carcinoma, Non-Small-Cell Lung Esophageal Neoplasms Osteosarcoma Disease Progression Lymphatic Metastasis Urinary Bladder Neoplasms Glioma Leukemia Biliary Tract Neoplasms

Chemicals and Drugs84

Epirubicin Antineoplastic Agents Antibiotics, Antineoplastic Doxorubicin Fluorouracil Cisplatin Paclitaxel Cyclophosphamide Antineoplastic Agents, Phytogenic Taxoids Etoposide Deoxycytidine Vinblastine Antineoplastic Agents, Alkylating Razoxane Methotrexate Antimetabolites, Antineoplastic Vincristine P-Glycoprotein Anthracyclines Mitomycin Daunorubicin Tumor Suppressor Protein p53 Carboplatin Proto-Oncogene Proteins c-bcl-2 Granulocyte Colony-Stimulating Factor Camptothecin Carmustine Dacarbazine Mitoxantrone Ifosfamide Bleomycin Caspases Organoplatinum Compounds Melphalan RNA, Small Interfering Noscapine Neoplasm Proteins Enzyme Inhibitors Receptor, erbB-2 Hycanthone Tamoxifen Apoptosis Regulatory Proteins Cytarabine Antibodies, Monoclonal bcl-X Protein Thioguanine Alkylating Agents Prolyl Hydroxylases DNA Topoisomerases, Type II Topoisomerase II Inhibitors Caspase 3 Poly(ADP-ribose) Polymerases Mitomycins RNA, Messenger Lomustine Prodrugs Radiation-Sensitizing Agents Tubulin Modulators Thiotepa bcl-2-Associated X Protein Multidrug Resistance-Associated Proteins Antibodies, Monoclonal, Humanized Naphthacenes Nitrosourea Compounds Cardiotoxins Recombinant Proteins Drug Carriers Mechlorethamine Topotecan Tumor Markers, Biological Nitrogen Mustard Compounds Tetrazolium Salts Antiemetics Arsenicals Isocoumarins Indazoles TNF-Related Apoptosis-Inducing Ligand Reactive Oxygen Species Pyrazines Tilorone Piperazines DNA-Binding Proteins Verapamil

Analytical, Diagnostic and Therapeutic Techniques and Equipment40

Antineoplastic Combined Chemotherapy Protocols Drug Administration Schedule Drug Screening Assays, Antitumor Treatment Outcome Chemotherapy, Adjuvant Xenograft Model Antitumor Assays Combined Modality Therapy Inhibitory Concentration 50 Infusions, Intravenous Disease-Free Survival Survival Analysis Neoadjuvant Therapy Survival Rate Neoplasm Transplantation Drug Delivery Systems Neoplasm Staging Drug Evaluation, Preclinical Blotting, Western Flow Cytometry Neoplasms, Experimental Injections, Intravenous Administration, Oral Transplantation, Heterologous Lethal Dose 50 Transfection Drug Evaluation Infusions, Intra-Arterial Drug Therapy, Combination Tumor Burden Reverse Transcriptase Polymerase Chain Reaction Maximum Tolerated Dose Prognosis Area Under Curve Clinical Trials as Topic Drug Carriers Immunohistochemistry Tumor Stem Cell Assay Follow-Up Studies Prospective Studies Remission Induction

Phenomena and Processes29

Drug Resistance, Neoplasm Apoptosis Drug Synergism Drug Resistance, Multiple Dose-Response Relationship, Drug Cell Survival Cell Proliferation Inhibitory Concentration 50 Time Factors Gene Expression Regulation, Neoplastic DNA Damage Cell Cycle Drug Interactions Cell Death Cell Division Drug Resistance Lethal Dose 50 Signal Transduction Transfection DNA Repair Down-Regulation Maximum Tolerated Dose Genes, p53 Area Under Curve Enzyme Activation Biotransformation Cell Growth Processes Up-Regulation RNA Interference

Disciplines and Occupations1

Immunohistochemistry

Information Science1

Health Care8

Treatment Outcome Disease-Free Survival Survival Analysis Survival Rate Area Under Curve Clinical Trials as Topic Follow-Up Studies Prospective Studies

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Information Science Health Care

Epirubicin Antineoplastic Agents Antibiotics, Antineoplastic Doxorubicin Antineoplastic Combined Chemotherapy Protocols Fluorouracil Cisplatin Paclitaxel Drug Resistance, Neoplasm Cyclophosphamide Breast Neoplasms Cell Line, Tumor Apoptosis Antineoplastic Agents, Phytogenic Taxoids Drug Synergism Drug Administration Schedule Etoposide Deoxycytidine Neoplasms Drug Resistance, Multiple Dose-Response Relationship, Drug Tumor Cells, Cultured Cell Survival Vinblastine Drug Screening Assays, Antitumor Antineoplastic Agents, Alkylating Razoxane Methotrexate Antimetabolites, Antineoplastic Treatment Outcome Chemotherapy, Adjuvant Vincristine P-Glycoprotein Anthracyclines Xenograft Model Antitumor Assays Combined Modality Therapy Mitomycin Daunorubicin Cell Proliferation Inhibitory Concentration 50 Mice, Nude Lung Neoplasms Time Factors Infusions, Intravenous Disease-Free Survival Tumor Suppressor Protein p53 Carboplatin Proto-Oncogene Proteins c-bcl-2 Survival Analysis Gene Expression Regulation, Neoplastic DNA Damage Cell Cycle Neoadjuvant Therapy Adenocarcinoma Granulocyte Colony-Stimulating Factor Camptothecin Carmustine Dacarbazine Mitoxantrone Neoplasm Metastasis Survival Rate Ifosfamide Ovarian Neoplasms Bleomycin Drug Interactions Neoplasm Transplantation Neutropenia Caspases Cell Death Colonic Neoplasms Drug Delivery Systems Stomach Neoplasms Cell Division Liver Neoplasms Vomiting Neoplasm Staging Organoplatinum Compounds Drug Resistance Melphalan RNA, Small Interfering Drug Evaluation, Preclinical Noscapine Alopecia Blotting, Western Neoplasm Proteins Flow Cytometry Neoplasms, Experimental Nausea Enzyme Inhibitors Receptor, erbB-2 Injections, Intravenous Mice, Inbred BALB C Pancreatic Neoplasms Administration, Oral Hycanthone Transplantation, Heterologous Lethal Dose 50 Tamoxifen Signal Transduction

No FAQ available that match "chemotherapeutic agents doses epirubicin"